Gene therapy method targets tumor blood vessels

Working in mice, Washington University School of Medicine researchers Jeffrey Arbeit, MD, and David Curiel, MD, PhD, report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells.

Arbeit, the senior author of the paper, is a professor of urologic surgery and of cell biology and physiology; Curiel is a distinguished professor of radiation oncology.

See press release.